Common use of Adverse Reaction Reporting Clause in Contracts

Adverse Reaction Reporting. (a) Each Party shall record, evaluate, summarize and review all adverse drug experiences associated with the Compound and the Product. In order that each Party may be fully informed of the adverse drug experiences associated therewith that are known to the other Party, each Party shall report: (i) In the case of Inspire, to: Inspire Pharmaceuticals, Inc. 0000 Xxxxxxx Xxxxxxxxx, Xxxxx 000 Xxxxxx, Xxxxx Xxxxxxxx 00000 XXX Attention: XxXxx Xxxxxx, Manager, Regulatory Affairs & Project Management Facsimile No.: (000) 000-0000 Telephone No.: (919) 941-9777 ext. 288 (ii) In the case of Santen, to: Santen Pharmaceutical Co., Ltd. 0-0-00 Xxxxxxxxxxx Xxxxxxxxxxxxxxx-xx Xxxxx 000-0000 XXXXX Attention: Xxxx Xxxxxxxx, Ph.D., Deputy General Manager Facsimile No.: (00) 0000-0000 Telephone No.: (00) 0000-0000

Adverse Reaction Reporting. (a) Each Party shall record, evaluate, summarize and review all adverse drug experiences associated with the Compound and the Product. In order that each Party may be fully informed of the adverse drug experiences associated therewith that are known to the other Party, each Party shall report: (i) In the case of Inspire, to: Inspire Pharmaceuticals, Inc. 0000 Xxxxxxx Xxxxxxxxx, Xxxxx 000 Xxxxxx, Xxxxx Xxxxxxxx 00000 XXX Attention: XxXxx XxxxxxXxxxxxxx Xxxxx, ManagerPh.D., Director, Regulatory Affairs & Project Management Facsimile No.: (000) 000-0000 Telephone No.: (919) 941-9777 ext. 288277 (ii) In the case of SantenKissei, to: Santen Kissei Pharmaceutical Co., Ltd. 0-0, Xxxxxxxxxx 0-00 Xxxxxxxxxxx XxxxxxxxxxxxxxxXxxxx, Xxxxxx-xx Xx, Xxxxx 000-0000 XXXXX Attention: Xxxx XxxxxxxxXxxxx Xxxxxx, Ph.D., Deputy General Manager Director, Member of the Board, Clinical Development, R & D Facsimile No.: (00) 000000)0000-0000 Telephone No.: (00) 000000)0000-0000